Siegfried Wurster
Chief Tech/Sci/R&D Officer at Karyon-CTT Oy
Profile
Siegfried Wurster is Chief Scientific Officer of Karyon-CTT Oy.
Prior to joining Karyon in 2006 he was Director of Sciences at Juvantia Pharma Ltd.
Dr. Wurster holds a PhD in Chemistry from the University of Freiburg.
Siegfried Wurster active positions
| Companies | Position | Start |
|---|---|---|
Karyon-CTT Oy
 Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland. | Chief Tech/Sci/R&D Officer | 31/12/2005 |
Former positions of Siegfried Wurster
| Companies | Position | End |
|---|---|---|
Juvantia Pharma Oy
 Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland. | Chief Tech/Sci/R&D Officer | - |
Training of Siegfried Wurster
| University of Freiburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Juvantia Pharma Oy
Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland. | Commercial Services |
Karyon-CTT Oy
Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland. | Commercial Services |
- Stock Market
- Insiders
- Siegfried Wurster
